In October 2022, the U.S. Food and Drug Administration (FDA) granted accelerated TECVAYLI™ (teclistamab-cqyv) FDA approval, a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. For the treatment of adult patients with relapsed or refractory…
What is Sulbactam-Durlobactam? Sulbactam Durlobactam is a new and special drug combination used to combat multidrug-resistant infections, particularly those caused by Acinetobacter baumannii-calcoaceticus complex, a serious and often difficult-to-treat pathogen. This combination of Sulbactam and…
About Vonvendi Vonvendi (vonicog alfa) is a recombinant von Willebrand factor (VWF) developed by Baxalta. It helps control bleeding episodes by replacing or supplementing the missing or dysfunctional VWF in patients, thereby improving their quality…
On October 15, 2023, the U.S. Food and Drug Administration (FDA) officially approved Enlonstobart Injection (development code: ENL-001) for the treatment of a rare genetic disorder, Idiopathic Fibrotic Syndrome (IFS). This groundbreaking therapy marks another…
The U.S. Food and Drug Administration (FDA) recently announced the approval of Besremi (generic name: ropeginterferon alfa-2b-njft) for the treatment of true erythrocytosis (Polycythemia Vera, PV). This decision marks Besremi as the first FDA-approved interferon…
UCB has recently announced that its innovative therapy, Bimzelx (generic name: bimekizumab-bkzx), has received approval from the U.S. Food and Drug Administration (FDA) for multiple new indications, solidifying its role in treating various immune-mediated inflammatory…
Lachen, Switzerland – Octapharma has announced that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe hemophilia A have been published in the medical journal…
In the world of immunology and asthma management, Benralizumab Injection has emerged as a game-changer for patients struggling with severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA). This monoclonal antibody, developed by AstraZeneca in…
The trade name of emapalumab lzsg is Gamifant, which is an anti interferon gamma (IFN gamma) antibody drug used to treat hemophagocytic lymphohistiocytosis (HLH). As a promising new option for patients with this rare and…
Introduction Lung cancer is one of the most common and serious types of cancer, but thanks to modern medicine, there have been significant advances in new medication for lung cancer over the past few years.…
In the field of cancer treatment, targeted therapies and antibody-drug conjugates (ADCs) are emerging as breakthrough treatment options. As one of the most important advances in this area, Padcev (generic name: Enfortumab Vedotin) has recently…
Recently, the U.S. Food and Drug Administration (FDA) officially approved Carvykti (Ciltacabtagene Autoleucel, or Cilta-cel), a CAR-T cell therapy jointly developed by Johnson & Johnson and Legend Biotech, for the treatment of adult patients with…
